Mechanisms underlying feed intolerance in the critically ill: implications for treatment. - Test2 - elhamkhani - TriplyDB

Mechanisms underlying feed intolerance in the critically ill: implications for treatment.

Mechanisms underlying feed intolerance in the critically ill: implications for treatment.

http://www.wikidata.org/entity/Q42909359

about

Clinical review: Optimizing enteral nutrition for critically ill patients--a simple data-driven formula Nutrition: A Primary Therapy in Pediatric Acute Respiratory Distress Syndrome A randomised controlled comparison of early post-pyloric versus early gastric feeding to meet nutritional targets in ventilated intensive care patients.Erythromycin versus neomycin in the treatment of hepatic encephalopathy in cirrhosis: a randomized double-blind study Effects of Rikkunshito (traditional Japanese medicine) on enteral feeding and the plasma ghrelin level in critically ill patients: a pilot study.Gastric Dysmotility in Critically Ill Children: Pathophysiology, Diagnosis, and Management.Comparative effects on glucose absorption of intragastric and post-pyloric nutrient delivery in the critically ill.Gastrointestinal failure score in critically ill patients: a prospective observational study.Intensive medical nutrition therapy: methods to improve nutrition provision in the critical care setting Modulation of individual components of gastric motor response to duodenal glucose The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study.Year in review 2007: Critical Care--shock Nutritional support to patients within the pediatric intensive setting.Approach to enteral feeding in the PICU.Current and future therapeutic prokinetic therapy to improve enteral feed intolerance in the ICU patient.Critical illness, gastrointestinal complications, and medication therapy during enteral feeding in critically ill adult patients.Comparisons between intragastric and small intestinal delivery of enteral nutrition in the critically ill: a systematic review and meta-analysis.Gastric residual volume in critically ill patients: a dead marker or still alive?Incretins: player or stayer?Enhanced Protein-Energy Provision via the Enteral Route in Critically Ill Patients (PEP uP Protocol): A Review of Evidence.Peri-operative nutrition.Prevalence, Outcomes, and Management of Enteral Tube Feeding Intolerance: A Retrospective Cohort Study in a Tertiary Center.Prevalence, risk factors, clinical consequences, and treatment of enteral feed intolerance during critical illness.Mesenteric blood flow, glucose absorption and blood pressure responses to small intestinal glucose in critically ill patients older than 65 years.A UK and Irish survey of enteral nutrition practices in paediatric intensive care units.Effects of early oral feeding on relapse and symptoms of upper gastrointestinal bleeding in peptic ulcer disease.Erythromycin vs metoclopramide for facilitating gastric emptying and tolerance to intragastric nutrition in critically ill patients.Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes.Auscultation of bowel sounds in critical care: the role of the nurse.Endogenous amylin and glucagon-like peptide-1 concentrations are not associated with gastric emptying in critical illness.Gastrointestinal hormone concentrations associated with gastric feeding in critically ill patients.Glucose Variability Measures as Predictors of Oral Feeding Intolerance in Acute Pancreatitis: A Prospective Pilot Study.Studying the effect of abdominal massage on the gastric residual volume in patients hospitalized in intensive care units

P2860

Q26825258-0540C753-C219-4C3F-9CEB-4E4C45C3CBBA Q28069270-DE4ED54E-E931-4ED7-8EDB-50CCD3397A48 Q33612657-9E396A8E-EF8D-4BF5-A4DA-5D1DA37E30D0 Q34550014-F62284D5-0119-4427-9AA4-D55B1D134803 Q35106671-18AB5A90-10CB-47F5-9292-B2D39E152547 Q36253697-78DAECBA-A7BA-486F-88D8-5ACB42204791 Q36928107-7B11F6AB-EE8E-49D2-81AD-06A08FBE6F8D Q36955207-E220B70D-FDFC-4F02-825E-D09B035D4BD0 Q37069443-95EA8DE7-35B4-4531-9A71-E6CD33D397BD Q37221523-54636E8C-6C9C-4BD2-820D-01BFB991A7E5 Q37279769-B7236963-0A38-4228-9F8C-EB8BB8CEFC44 Q37317235-FEFBD64B-0762-41EC-ABFA-DF8319662450 Q37427862-DC6D9138-D532-4378-9D7A-078B1204D0E6 Q37502449-B8468677-B4CC-4101-9D38-A169E493AF24 Q37686926-847AFB1B-F949-4976-AC95-B0BE5D250732 Q37686927-0D4CA28A-FF62-42CB-8CFA-CDE9D5C86B9D Q38116967-B2B4C023-9248-4E04-AECC-3A62D7CB610B Q38294312-E48E4D2B-46BA-4E00-8F75-9488253E6C5E Q38432296-E0ECF141-1A3F-4AEC-9739-F4F82C4ADEFD Q38589434-836B7BB2-4640-44DA-BA92-2CDDBB73ABA8 Q38653562-3A9278E4-AD43-42A3-8795-03D863937122 Q38724577-B60A6E8B-1457-44C6-B2E4-F2CA2A7A253F Q44859515-1DE08BD7-DAE6-4D01-B10A-259809554EF4 Q45096202-4C1F1C3F-1B9C-42B1-A600-A7FF8B57ED67 Q45816177-9A4E935E-F0D9-4A4C-A9BE-CC15FAA8CAA9 Q46021178-199B3631-A1B1-4698-B6C0-D43AE109AB7F Q46506002-52692797-66F6-428F-A42A-CA376E970264 Q47113158-07D35BE2-962B-4EA1-A5DC-A67D6F849175 Q49683325-BAC30061-69F6-43E7-8C27-374D013F3B14 Q51328766-315E1571-4499-4064-A266-16B6146AC4DA Q51370200-6B081163-221C-496F-B659-7F0DEB11321D Q53434911-524E1740-0B73-4B56-B3EF-0507362AA70F Q58791607-BBE08271-AFB6-458D-9DFA-3FDD1B464B84

P2860

Mechanisms underlying feed intolerance in the critically ill: implications for treatment.

http://www.wikidata.org/entity/Q42909359

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Mechanisms underlying feed intolerance in the critically ill: implications for treatment.

@en

Mechanisms underlying feed intolerance in the critically ill: implications for treatment.

@nl

type

label

Mechanisms underlying feed intolerance in the critically ill: implications for treatment.

@en

Mechanisms underlying feed intolerance in the critically ill: implications for treatment.

@nl

prefLabel

Mechanisms underlying feed intolerance in the critically ill: implications for treatment.

@en

Mechanisms underlying feed intolerance in the critically ill: implications for treatment.

@nl

P1433

Q42909359-2ED51246-237A-494D-8579-2EADE644E2B7

P1476

Q42909359-576E0D1C-CB2F-4170-BB32-B115E5E47D79

P2093

Q42909359-0772D3EF-1248-4464-AEB2-09CB7F3DCF59

Q42909359-36EF4B3F-53D1-43D1-B915-FC0BB736EE19

Q42909359-747B4984-EEE2-43D9-BF0D-5F5B5F64601E

Q42909359-8957733C-F4C6-4C71-985F-B9B6E7D75EB5

Q42909359-A40D0755-A215-4C5A-B9CC-2F20512FDCBF

Q42909359-FCF1B4CF-EEA4-4E7C-84C4-BC655B96AE18

P2860

Q42909359-01B77862-70B1-432E-B2B0-86D26EF48CDF

Q42909359-027F9791-0124-472E-AF16-40F31457CC24

Q42909359-029D0561-A515-42A5-9434-E5F2BF8FD692

Q42909359-072ABC7A-50C4-489C-9746-2749389281D4

Q42909359-0B28AF38-B9C6-40D8-838D-275A8627F4A5

Q42909359-174E3AF6-FC93-465B-A04C-AB8DB619DA89

Q42909359-18A80640-43F6-4AB7-A07D-61E210A72B56

Q42909359-19C1083A-ADFB-4FC5-A220-65308456FED4

Q42909359-1B074B75-F18F-43DA-9B42-DDB0A24E0EB2

Q42909359-25CC098C-8C8B-46FE-B6B7-07CB30BE9AB8

P304

Q42909359-A7021131-90B0-40B4-A0E3-F215D15B4CF9

P31

Q42909359-648445aa-3801-4b5f-8578-c01018202d5f

Q42909359-DB025CF0-B14D-4035-98A4-4252086E2723

P356

Q42909359-3389A64F-FC71-49AD-B902-3B6B21D16C6F

P407

Q42909359-38E04786-1591-443A-A4A4-6FEF1A1E65F6

P433

Q42909359-FFD1A200-A968-4E7F-A501-1D1E5BD49768

P478

Q42909359-6A70717E-3465-4377-BF86-E377DD80583E

P577

Q42909359-5A372EDA-FF82-4CC1-A782-86BD0708788E

P5875

Q42909359-36545090-AC9D-452E-9415-0F8D435393B1

P698

Q42909359-19171DB2-E5E8-445C-87AC-710F863D23C7

P932

Q42909359-E41DAB28-EC99-4E7B-9EC3-772C48B7F97C

P356

WJG.V13.I29.3909

P1433

World Journal of Gastroenterology

P1476

Mechanisms underlying feed intolerance in the critically ill: implications for treatment.

@en

P2093

Adam Deane

http://www.w3.org/2001/XMLSchema#string

Carly Burgstad

http://www.w3.org/2001/XMLSchema#string

Laura K Bryant

http://www.w3.org/2001/XMLSchema#string

Marianne J Chapman

http://www.w3.org/2001/XMLSchema#string

Nam Q Nguyen

http://www.w3.org/2001/XMLSchema#string

Robert J Fraser

http://www.w3.org/2001/XMLSchema#string

P2860

Gastric versus post-pyloric feeding: a systematic review

Ghrelin: a new player in the control of gastrointestinal functions

Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction--a 21-day treatment-randomized clinical trial.

Selective postoperative inhibition of gastrointestinal opioid receptors.

Proximal gastric motility in critically ill patients with type 2 diabetes mellitus.

Proximal gastric response to small intestinal nutrients is abnormal in mechanically ventilated critically ill patients.

Increased mortality associated with growth hormone treatment in critically ill adults.

Impacts and patterns of disturbed gastrointestinal function in critically ill patients.

Hyperglycaemia stimulates pyloric motility in normal subjects.

Basic and clinical pharmacology of new motility promoting agents.

P304

3909-3917

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V13.I29.3909

http://www.w3.org/2001/XMLSchema#string

P407

P433

29

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273360120

http://www.w3.org/2001/XMLSchema#string

P698

17663503

http://www.w3.org/2001/XMLSchema#string

P932

4171161

http://www.w3.org/2001/XMLSchema#string